Procurement managers at life sciences organizations like biotechnology, pharmaceutical, and research institutions know how challenging it can be to help keep scientists and their labs fully stocked while still managing to the budget.
The current common model, where only the catalogs of one or two large suppliers are available purchasing departments and researchers doesn’t help.
One of the largest challenges faced by procurement professionals in managing indirect spend. Indirect spend shows up in several ways:
In a broad sense, “tail spend” refers to unmanaged spending. Each business or team may have their own specific definitions of tail spend, but it is inclusive of
Some of the above may simply be an education issue with buyers, but it can also be a challenge of competing priorities. Researchers may simply not have the time to wait for an approved supplier to restock critical materials, despite what the procurement policy is.
Procurement, too, may be forced to go off catalog in order to keep laboratories stocked, even when they prefer not to.
In the life sciences, third-party spend refers to those products that are supplied by a traditional, managed supplier, but are not the proprietary products of the supplier; hence, these items come with a markup.
However, even though the supplies are coming from a contracted, approved supplier, purchasers simply don’t have the same negotiating power when it comes to third-party products. While third-party spend is a significant source of revenue for large distributors and manufacturers, it is also a significant source of hard-to-manage cost for procurement departments.
This is one of the more challenging spend categories to manage, as suppliers have little incentive to share information about third-party products
While corporate e-procurement has modernized extensively, enterprise procurement applications often don’t have the flexibility or the vertical awareness to allow life sciences procurement to onboard a variety of supplier catalogs quickly. This creates the unintended consequences of vendor lock in, and in some cases can create weaknesses in supply chain resiliency. The lack of diversity in supplier catalogs can push that indirect spend simply through lack of options.
Yet, point solutions often aren’t robust enough to go all the way through the purchase-to-pay process or can create additional work for accounts payable.
To help manage indirect spend—and virtually eliminate third-party spend—B2B marketplaces like Labviva integrate with well-known procurement solutions like JAGGAER Procure-to-Pay, SAP Ariba, or Oracle Procurement Cloud to offer access to any supplier in the network.
This effectively solves the problem of onboarding new catalogs, while also surfacing data that procurement teams need to improve supplier management.